Impact of ADME Toxicology Testing on Patient Safety
The ADME Toxicology Testing Market directly contributes to patient safety by enabling early identification of potentially harmful drug effects. By characterizing how a drug is absorbed, metabolized, distributed, and excreted, these tests help predict adverse reactions and drug interactions before clinical trials.
Improved ADME profiling reduces the risk of late-stage failures and post-market withdrawals, thereby safeguarding patients and healthcare systems. Enhanced testing accuracy also supports the development of personalized therapies with better safety margins.
1 View